Pharma & Healthcare

Global Valganciclovir Market Research Report 2025

Report Scope
This report aims to provide a comprehensive presentation of the global market for Valganciclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valganciclovir.
The Valganciclovir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Valganciclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valganciclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Rakshit Drugs
United Biotech Private Limited
Roche
Segment by Type
Powder
Tablet
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valganciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valganciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 Valganciclovir Market Overview
1.1 Product Definition
1.2 Valganciclovir by Type
1.2.1 Global Valganciclovir Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Tablet
1.3 Valganciclovir by Application
1.3.1 Global Valganciclovir Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Global Valganciclovir Market Size Estimates and Forecasts
1.4.1 Global Valganciclovir Revenue 2020-2031
1.4.2 Global Valganciclovir Sales 2020-2031
1.4.3 Global Valganciclovir Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Valganciclovir Market Competition by Manufacturers
2.1 Global Valganciclovir Sales Market Share by Manufacturers (2020-2025)
2.2 Global Valganciclovir Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Valganciclovir Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Valganciclovir, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valganciclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valganciclovir, Product Type & Application
2.7 Global Key Manufacturers of Valganciclovir, Date of Enter into This Industry
2.8 Global Valganciclovir Market Competitive Situation and Trends
2.8.1 Global Valganciclovir Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Valganciclovir Players Market Share by Revenue
2.8.3 Global Valganciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Valganciclovir Market Scenario by Region
3.1 Global Valganciclovir Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Valganciclovir Sales by Region: 2020-2031
3.2.1 Global Valganciclovir Sales by Region: 2020-2025
3.2.2 Global Valganciclovir Sales by Region: 2026-2031
3.3 Global Valganciclovir Revenue by Region: 2020-2031
3.3.1 Global Valganciclovir Revenue by Region: 2020-2025
3.3.2 Global Valganciclovir Revenue by Region: 2026-2031
3.4 North America Valganciclovir Market Facts & Figures by Country
3.4.1 North America Valganciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Valganciclovir Sales by Country (2020-2031)
3.4.3 North America Valganciclovir Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valganciclovir Market Facts & Figures by Country
3.5.1 Europe Valganciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Valganciclovir Sales by Country (2020-2031)
3.5.3 Europe Valganciclovir Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valganciclovir Market Facts & Figures by Region
3.6.1 Asia Pacific Valganciclovir Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Valganciclovir Sales by Region (2020-2031)
3.6.3 Asia Pacific Valganciclovir Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valganciclovir Market Facts & Figures by Country
3.7.1 Latin America Valganciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Valganciclovir Sales by Country (2020-2031)
3.7.3 Latin America Valganciclovir Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valganciclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Valganciclovir Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Valganciclovir Sales by Country (2020-2031)
3.8.3 Middle East and Africa Valganciclovir Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Valganciclovir Sales by Type (2020-2031)
4.1.1 Global Valganciclovir Sales by Type (2020-2025)
4.1.2 Global Valganciclovir Sales by Type (2026-2031)
4.1.3 Global Valganciclovir Sales Market Share by Type (2020-2031)
4.2 Global Valganciclovir Revenue by Type (2020-2031)
4.2.1 Global Valganciclovir Revenue by Type (2020-2025)
4.2.2 Global Valganciclovir Revenue by Type (2026-2031)
4.2.3 Global Valganciclovir Revenue Market Share by Type (2020-2031)
4.3 Global Valganciclovir Price by Type (2020-2031)
5 Segment by Application
5.1 Global Valganciclovir Sales by Application (2020-2031)
5.1.1 Global Valganciclovir Sales by Application (2020-2025)
5.1.2 Global Valganciclovir Sales by Application (2026-2031)
5.1.3 Global Valganciclovir Sales Market Share by Application (2020-2031)
5.2 Global Valganciclovir Revenue by Application (2020-2031)
5.2.1 Global Valganciclovir Revenue by Application (2020-2025)
5.2.2 Global Valganciclovir Revenue by Application (2026-2031)
5.2.3 Global Valganciclovir Revenue Market Share by Application (2020-2031)
5.3 Global Valganciclovir Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Rakshit Drugs
6.1.1 Rakshit Drugs Company Information
6.1.2 Rakshit Drugs Description and Business Overview
6.1.3 Rakshit Drugs Valganciclovir Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Rakshit Drugs Valganciclovir Product Portfolio
6.1.5 Rakshit Drugs Recent Developments/Updates
6.2 United Biotech Private Limited
6.2.1 United Biotech Private Limited Company Information
6.2.2 United Biotech Private Limited Description and Business Overview
6.2.3 United Biotech Private Limited Valganciclovir Sales, Revenue and Gross Margin (2020-2025)
6.2.4 United Biotech Private Limited Valganciclovir Product Portfolio
6.2.5 United Biotech Private Limited Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Valganciclovir Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Valganciclovir Product Portfolio
6.3.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valganciclovir Industry Chain Analysis
7.2 Valganciclovir Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valganciclovir Production Mode & Process Analysis
7.4 Valganciclovir Sales and Marketing
7.4.1 Valganciclovir Sales Channels
7.4.2 Valganciclovir Distributors
7.5 Valganciclovir Customer Analysis
8 Valganciclovir Market Dynamics
8.1 Valganciclovir Industry Trends
8.2 Valganciclovir Market Drivers
8.3 Valganciclovir Market Challenges
8.4 Valganciclovir Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Valganciclovir Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Valganciclovir Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Valganciclovir Market Competitive Situation by Manufacturers in 2024
Table 4. Global Valganciclovir Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Valganciclovir Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Valganciclovir Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Valganciclovir Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Valganciclovir Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Valganciclovir, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Valganciclovir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Valganciclovir, Product Type & Application
Table 12. Global Key Manufacturers of Valganciclovir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Valganciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valganciclovir as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Valganciclovir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Valganciclovir Sales by Region (2020-2025) & (K Units)
Table 18. Global Valganciclovir Sales Market Share by Region (2020-2025)
Table 19. Global Valganciclovir Sales by Region (2026-2031) & (K Units)
Table 20. Global Valganciclovir Sales Market Share by Region (2026-2031)
Table 21. Global Valganciclovir Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Valganciclovir Revenue Market Share by Region (2020-2025)
Table 23. Global Valganciclovir Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Valganciclovir Revenue Market Share by Region (2026-2031)
Table 25. North America Valganciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Valganciclovir Sales by Country (2020-2025) & (K Units)
Table 27. North America Valganciclovir Sales by Country (2026-2031) & (K Units)
Table 28. North America Valganciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Valganciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Valganciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Valganciclovir Sales by Country (2020-2025) & (K Units)
Table 32. Europe Valganciclovir Sales by Country (2026-2031) & (K Units)
Table 33. Europe Valganciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Valganciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Valganciclovir Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Valganciclovir Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Valganciclovir Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Valganciclovir Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Valganciclovir Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Valganciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Valganciclovir Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Valganciclovir Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Valganciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Valganciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Valganciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Valganciclovir Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Valganciclovir Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Valganciclovir Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Valganciclovir Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Valganciclovir Sales (K Units) by Type (2020-2025)
Table 51. Global Valganciclovir Sales (K Units) by Type (2026-2031)
Table 52. Global Valganciclovir Sales Market Share by Type (2020-2025)
Table 53. Global Valganciclovir Sales Market Share by Type (2026-2031)
Table 54. Global Valganciclovir Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Valganciclovir Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Valganciclovir Revenue Market Share by Type (2020-2025)
Table 57. Global Valganciclovir Revenue Market Share by Type (2026-2031)
Table 58. Global Valganciclovir Price (USD/Unit) by Type (2020-2025)
Table 59. Global Valganciclovir Price (USD/Unit) by Type (2026-2031)
Table 60. Global Valganciclovir Sales (K Units) by Application (2020-2025)
Table 61. Global Valganciclovir Sales (K Units) by Application (2026-2031)
Table 62. Global Valganciclovir Sales Market Share by Application (2020-2025)
Table 63. Global Valganciclovir Sales Market Share by Application (2026-2031)
Table 64. Global Valganciclovir Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Valganciclovir Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Valganciclovir Revenue Market Share by Application (2020-2025)
Table 67. Global Valganciclovir Revenue Market Share by Application (2026-2031)
Table 68. Global Valganciclovir Price (USD/Unit) by Application (2020-2025)
Table 69. Global Valganciclovir Price (USD/Unit) by Application (2026-2031)
Table 70. Rakshit Drugs Company Information
Table 71. Rakshit Drugs Description and Business Overview
Table 72. Rakshit Drugs Valganciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Rakshit Drugs Valganciclovir Product
Table 74. Rakshit Drugs Recent Developments/Updates
Table 75. United Biotech Private Limited Company Information
Table 76. United Biotech Private Limited Description and Business Overview
Table 77. United Biotech Private Limited Valganciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. United Biotech Private Limited Valganciclovir Product
Table 79. United Biotech Private Limited Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche Valganciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Roche Valganciclovir Product
Table 84. Roche Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Valganciclovir Distributors List
Table 88. Valganciclovir Customers List
Table 89. Valganciclovir Market Trends
Table 90. Valganciclovir Market Drivers
Table 91. Valganciclovir Market Challenges
Table 92. Valganciclovir Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report


List of Figures
Figure 1. Product Picture of Valganciclovir
Figure 2. Global Valganciclovir Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Valganciclovir Market Share by Type: 2024 & 2031
Figure 4. Powder Product Picture
Figure 5. Tablet Product Picture
Figure 6. Global Valganciclovir Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Valganciclovir Market Share by Application: 2024 & 2031
Figure 8. Adults
Figure 9. Children
Figure 10. Global Valganciclovir Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Valganciclovir Market Size (2020-2031) & (US$ Million)
Figure 12. Global Valganciclovir Sales (2020-2031) & (K Units)
Figure 13. Global Valganciclovir Average Price (USD/Unit) & (2020-2031)
Figure 14. Valganciclovir Report Years Considered
Figure 15. Valganciclovir Sales Share by Manufacturers in 2024
Figure 16. Global Valganciclovir Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Valganciclovir Players: Market Share by Revenue in Valganciclovir in 2024
Figure 18. Valganciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Valganciclovir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Valganciclovir Sales Market Share by Country (2020-2031)
Figure 21. North America Valganciclovir Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Valganciclovir Sales Market Share by Country (2020-2031)
Figure 25. Europe Valganciclovir Revenue Market Share by Country (2020-2031)
Figure 26. Germany Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Valganciclovir Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Valganciclovir Revenue Market Share by Region (2020-2031)
Figure 33. China Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Valganciclovir Sales Market Share by Country (2020-2031)
Figure 44. Latin America Valganciclovir Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Valganciclovir Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Valganciclovir Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. U.A.E Valganciclovir Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Valganciclovir by Type (2020-2031)
Figure 54. Global Revenue Market Share of Valganciclovir by Type (2020-2031)
Figure 55. Global Valganciclovir Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Valganciclovir by Application (2020-2031)
Figure 57. Global Revenue Market Share of Valganciclovir by Application (2020-2031)
Figure 58. Global Valganciclovir Price (USD/Unit) by Application (2020-2031)
Figure 59. Valganciclovir Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies